The treatment of Conclusion This technique is recommended as a safe and effective method of treating bleb en capsulation.
Encapsulation of the filtering bleb occurs in approximately 13% of eyes following trabeculectomy and is increasing in incidence, 1 partly due to the detrimental effect of topical therapy on conjunctival and episcleral fibroblasts?-4 Encapsulation occurs in the early post-operative period, when adhesions form between the episcleral tissues and Tenon's capsule creating a fibrous, vascular cyst that entraps aqueous and creates a localised, dome shaped bleb. The associated intraocular pressure (lOP) rise peaks in the first 6 weeks post-operatively and may cause additional optic nerve head damage in vulnerable eyes.
Ocular hypotensive agents, steroids and ocular massage are frequently used as the primary therapy for bleb encapsulation, with resort to surgical management should the lOP remain inadequately controlled. Although conservative management may achieve an acceptable reduction in lOP in 70% of cases, 50% of these will require prolonged topical treatmen�,5,6 that may prejudice the results of d .
4
repeat ramage surgery. Early needle manipulation of the encapsulated bleb is an alternative approach that is gaining popularity. Primary needling of encapsulated blebs under the operating microscope has been shown to be a safe method of re-establishing function in 69% of cases? Recent advances in the technique and widespread use of 5-fluorouracil (5-FU) have enabled needling to be performed for bleb failure under slit-lamp magnification with success rates between 73% and 91 %. 8 -12 We report a series of 32 eyes which have been treated with bleb needling and adjuvant 5-FU therapy for bleb encapsulation and analyse our results. (Table 2 ) and had been treated with an intraoperative sponge application of 5-FU. All eyes had an initial period of good lOP control after drainage surgery, the mean interval between this surgery and bleb encapsulation being 9.7 ± 26.9 weeks (range 2-156 weeks). Four patients developed encapsulation more than 8 weeks after trabeculectomy; in each case an intraocular procedure had been performed in the intervening period (3 eyes underwent cataract extraction, 1 a vitrectomy). The mean interval between the last intraocular procedure and encapsulation in all 32 eyes was 3.3 ± 1.2 weeks (range 2-8 weeks). Encapsulation of the bleb was diagnosed on the basis of the appearance of the bleb (a domed, localised bleb with absent conjunctival microcystic changes) and the presence of a patent sclerostomy on gonioscopic examination. Where these features were accompanied by an lOP that was considered higher than acceptable for the degree of optic disc cupping and visual field loss, bleb needling was performed. In this group, all patients had an lOP of 18 mmHg or more (mean 29.2 ± 10.5 mmHg, range 18-60 mmHg) prior to needling.
Needling was performed as a primary procedure in 14 eyes (43.7%); in the other 18 (56.3%) needling was performed 1.1 ± 1.3 weeks (range 1-4 weeks) after conservative therapy had been initiated and subsequently proved inadequate for lOP control (Fig. 1 ).
Technique of bleb needling
Informed consent was obtained from all patients prior to needling. After instillation of topical anaesthetic, the patient was seated at the slit-lamp and directed to look down while an assistant retracted the upper lid. With the superior conjunctiva adequately exposed and taking care not to desterilise the needle on the lid margins or lashes, a 30 gauge needle attached to an insulin syringe was used to enter the subconjunctival space approximately 10 mm temporal to the cyst. The needle was advanced in the subconjunctival space and the needle point was used to perforate the wall of the cyst several times -as the needle pierced the cyst wall it was eased from side to side, thus enlarging the perforations until a rush of sub conjunctival aqueous and bleb inflation was seen (Fig. 2 ).
Great care was taken not to button-hole the conjunctiva overlying the drainage site. Following slow withdrawal of the needle, the conjunctival entry point was examined for the presence of an aqueous leak using the Seidel test.
If Seidel-positive, the puncture point was tamponaded for several minutes with a sterile cotton bud. Using a strict isolation technique and care to avoid accidental spillage, 5 mg (0.2 ml of 25 mg/ml solution) of 5-FU was then drawn into a second insulin syringe. The needle point was directed into the subconjunctival space 
Number of needling procedures
In total, 64 needling procedures (mean 2 ± 0.9 revisions per eye, range 1-4) were performed on 32 eyes. The mean length of follow-up was 10.7 ± 2.9 months (range 4-18 months) after the last needle revision. Eleven (34.4%) eyes required one needling procedure, 12 (37.5%) required two procedures (mean interval between first and second needling: 2.1 ± 1.6 weeks), 7 (21.8%) required three procedures (interval between second and third needling: 2 ± 1.2 weeks), and 2 (6.3%) eyes required four procedures (interval between third and fourth needling: 3 weeks).
lOP control
The mean lOP of the group decreased from 29.2 ± 10.5 mmHg (range 18-60 mmHg) prior to the first needling to 15.9 ± 4.0 mmHg (range 8-22 mmHg) at last follow-up (two-tailed paired Student's t-test p = 1.3 X 10-7). The scatterplot in Fig. 3 illustrates the relationship between pre-needling and follow-up lOP measurements. Overall, the mean drop in lOP associated with needling was 15.9 ± 8.3 mmHg (range 2-40 mmHg): the lOP reduction in eyes needled as a primary procedure was 16.4 ± 2.9 mmHg compared with 15.4 ± 4.7 mmHg in those needled after initiation of glaucoma medication (two tailed unpaired t-test p = 0.5).
Of the 32 eyes, 23 (71.9%) achieved a successful result, 5 (15.6%) were qualified successes (all had lOPs of less than 22 mmHg without treatment) and the remaining 4 (12.5%) were considered failures, with lOPs between 20 and 22 mmHg with one topical medication (beta-blockers in two cases, dorzolamide and latanoprost in one case each). The relationship between number of needling revisions and outcome is illustrated in Table 3 . The long term success rate after one needling revision was 25%; after two needlings the cumulative success rate was 56.3%. Fifteen (65.2%) of the eyes that maintained successful lOP control required more than one needling procedure. (%)
No.
(%)
(%) The success rate for phakic eyes was 70.8% and that for pseudophakic and aphakic eyes 75% (X2 test p>O.5). The success rate for primarily needled eyes was 78.6% and that for eyes needled after initiation of medication 66.7% (l test p>0.5).
In the group with a successful result the lOP decreased from a mean of 28.0 ± 9.6 mmHg prior to needling to 13.9 ± 2.9 mmHg (two-tailed paired Student's t-test p = 2.0 X 10-7); the mean lOP decreased from 27.8 ± 8.8 mmHg to 20.8±OA mmHg (p = 0.19) in the qualified success group. In the failure group the lOP decreased from 38 ± 12.7 mmHg to 21 ± 0.7 mmHg (p = 0.11), but all patients in this group had a long-term decrease in lOP of at least 30% of their initial measurement.
Bleb appearance
The long-term appearance of the needled blebs was unusual, most of the blebs being shaped like an inverted L with extension towards the side where the needling had been performed. At the last review none of the blebs was thin-walled or Seidel-positive.
Complications
The procedure was generally well tolerated, only one patient refusing a second needling procedure (he maintained an lOP of 21 mmHg without treatment and was a qualified success). Over the follow-up period none of the 32 patients lost more than one line of Snellen visual acuity. Twenty-two (68.8%) patients maintained the same visual acuity as that recorded prior to trabeculectomy and in 4 (12.5%) cases the Snellen visual acuity improved by two lines or more (these patients had undergone phacotrabeculectomy or secondary cataract extraction). Two (6.3%) eyes developed choroidal detachments that occurred within 3 days of needling; the lOP drop with needling prior to choroidal effusion was 15 mmHg and 25 mmHg respectively. The detachments resolved within 1 month after conservative treatment with mydriatics and topical steroids and did not result in long-term reduction in visual acuity. No persistent bleb leaks or corneal epithelial defects were noted at the clinic visits after the needling procedures.
Discussion
The safe and efficient treatment of bleb encapsulation is becoming an increasingly important skill in glaucoma management. Whilst aggressive medical therapy may lower the lOP in 70% of cases, the level of control may not be sufficient to prevent further glaucomatous damage and it may become a prolonged requirement.1,2.5,6 Several reports have indicated that prophylactic, post-operative 5-FU therapy inhibits bleb scarring (leading to a flattened bleb) but does not influence bleb encapsulation?·15. 16 In our study, 65.6% of the eyes with encapsulated blebs had received prophylactic, per-operative 5-FU. Furthermore, 28.1 % of these needled blebs had initially been treated with subconjunctival 5-FU injection (5 mg in 0.2 ml), without response, suggesting that 5-FU therapy alone does not alter the natural history of bleb encapsulation. Four (12.5%) of the eyes in this study developed bleb encapsulation only after a second intraocular procedure. Aggressive post-operative steroid therapy may be required to reduce the incidence of subsequent bleb encapsulation in these eyes.
Surgical bleb revision has been performed under the operating microscope with a similar success rate to medical therapy? More recently, the less invasive technique using a 30 gauge needle under slit-lamp magnification has become popular. [8] [9] [10] [11] [12] 14 This technique is particularly suitable for encapsulated blebs, where the resistance to aqueous drainage is a localised, raised, fibrous barrier in the subconjunctival layer that is amenable to perforation. Theoretically, the use of adjuvant anti-metabolites such as 5-FU and mitomycin C (MMC) after needling may inhibit subsequent bleb scarring, if not re-encapsulation, but no prospective, controlled studies have been performed to confirm this.
In The most commonly encountered complications in previous studies of needling with 5-FU have been corneal epithelial defects, hyphaema and bleb leaks, 8 �11 but 5-FU may cause additional serious intraocular complications if it gains access to the anterior chamber via the bleb.1R, 21 We advise performing the needling and 5-FU injection separately; injecting the 5-FU 3-4 mm superior to the upper limit of the bleb, which maximises its concentration around the bleb but prevents its direct entry into anterior chamber. Choroidal effusions have been associated with the lOP drop following needling with 5-FU and MMC.14,19 Two of 32 (6.3%) eyes developed choroidal effusions in our study that resolved with conservative therapy and without visual sequelae. It would seem wise to treat those cases where the lOP is over 30 mmHg with ocular hypotensive therapy prior to needling, in order to reduce the risk of choroidal effusion and detachment. To our knowledge there has been only one case of endophthalmitis following needling,12 but, since needling is an intraocular procedure, all possible precautions should be taken to prevent its occurrence. Although povidone-iodine 5% was not used to clean the lids and ocular surfaces prior to needling in this retrospective study, its efficacy in decreasing the conjunctival bacterial count has been demonstrated. 17, 20 We now advise the use of povidone-iodine prior to needling and a prophylactic course of topical antibiotics after the procedure.
This retrospective study reviewed the results of bleb needling and 5-FU in a small and disparate group of glaucoma patients and its design limits the conclusions that can be drawn from the data. It does illustrate, however, that needling is effective in immediately lowering the lOP and providing continued control over a 10 month period in patients with bleb encapsulation, that many patients will require two or more needlings to successfully maintain lOP control and that the complication rate is low. A long-term, prospective, case controlled study is required to confirm its advantages over conservative therapy for bleb encapsulation.
Bleb encapsulation is becoming an increasingly common challenge for the ophthalmologist. Although medical therapy may be successful in many cases, early bleb manipulation appears to offer a convenient, safe and efficacious method of gaining immediate lOP control and reducing the requirement for long-term glaucoma therapy.
